Top Amoxicillin Brands You Should Know About

Amoxicillin remains one of the most commonly prescribed antibiotics, crucial for treating a variety of bacterial infections. With several pharmaceutical companies producing this essential medication, choosing the right brand can be a daunting task for many. From globally recognized names to emerging companies, the array of options ensures that patients have access to quality and effective choices. For a comprehensive guide to the top brands offering amoxicillin, continue reading below.

Illustration of amoxicillin

Best brands of amoxicillin in 2025

GlaxoSmithKline

GSK, formerly known as GlaxoSmithKline, has been a major producer of amoxicillin, a widely used antibiotic, with a significant manufacturing facility in Singapore that has been the single source of amoxicillin for their global antibiotic production; they produce the active pharmaceutical ingredient (API) for brands like Amoxil and Augmentin. Although GSK has announced it will cease amoxicillin manufacturing at its Quality Road site in Singapore by the end of 2024, they remain a key player in the pharmaceutical industry, having produced over one million tons of amoxicillin cumulatively until 2020, demonstrating their large-scale manufacturing capacity. They offer amoxicillin in various formulations including capsules and oral suspensions. You can find more information about their products at their official website.

Teva Pharmaceuticals

Teva Pharmaceuticals is a significant global producer of amoxicillin, offering various formulations like capsules and oral suspensions, and their products are considered a bioequivalent to the brand-name Amoxil. Teva's amoxicillin is available in multiple dosages, such as 250mg/5ml suspension and 500mg capsules, catering to diverse patient needs and has been a trusted manufacturer since the patent expired in 1998. Teva also produces a chewable tablet form, with a 250 mg strength and a 125mg strength, and the company adheres to stringent quality controls, ensuring that their amoxicillin products meet international standards. Teva's amoxicillin is available as generic options, helping to reduce the cost of this essential antibiotic. For more information, visit their website.

Novartis

Sandoz, a division of Novartis, is a leading global producer of amoxicillin, with a strong commitment to quality. In 2023, Sandoz produced over 1.5 billion doses of various antibiotics, including amoxicillin, holding a significant share of the market. They ensure consistent supply and affordability, underscoring Sandoz's role as a key supplier of this essential antibiotic, which is used to treat bacterial infections. Their commitment to providing access to high-quality medicines is a testament to their dedication.

Aurobindo Pharma

Aurobindo Pharma is a prominent global pharmaceutical company, known for its production of amoxicillin, a widely used antibiotic, with a market presence that contributes to the estimated $4.74 billion global market in 2024; they offer amoxicillin in various forms, including capsules and oral suspensions, and are a key player in supplying this essential medication to treat bacterial infections, while also focusing on supply chain optimization and manufacturing capabilities. Aurobindo's amoxicillin products are available in multiple strengths, such as 500mg capsules and 875mg tablets, catering to different patient needs and are manufactured under strict quality controls.

Hikma Pharmaceuticals

Hikma Pharmaceuticals, a multinational company founded in 1978, is a notable producer of generic medications, including amoxicillin, with a significant presence in the US market, offering it in both oral and injectable forms. While facing increased demand and supply allocation in 2022, Hikma continues to provide various amoxicillin products, including capsules and suspensions, and is recognized as one of the major players in the global amoxicillin market. Hikma's amoxicillin products are available in various strengths, such as a 250mg/5ml suspension and 500mg capsules.

Lupin Pharmaceuticals

Lupin Pharmaceuticals has established itself as a leading manufacturer of amoxicillin, a critical antibiotic, with a robust production capacity that ensures a consistent supply to global markets; in 2023, Lupin held approximately 15% of the global amoxicillin market share, demonstrating its significance in the pharmaceutical landscape, and the company continues to invest in advanced manufacturing techniques to maintain high-quality standards; Lupin's amoxicillin products are available in various dosages and formulations, catering to diverse patient needs; they are committed to providing accessible and affordable healthcare solutions.

Mylan

Viatris, formerly Mylan, is a significant global pharmaceutical company that produces amoxicillin, a widely used antibiotic, with a focus on maintaining high-quality manufacturing standards at their own and their supplier's sites. While specific market share data for Viatris' amoxicillin production isn't readily available, the global amoxicillin market is projected to reach $6.64 billion by 2034, with amoxicillin being a leading antibiotic prescribed for various bacterial infections. It is noteworthy that in 2023, around 18.26% of all antibiotic prescriptions in the US were for amoxicillin, highlighting its importance, though Mylan-Amoxicillin is no longer sold in Canada.

Sun Pharmaceutical

Sun Pharmaceutical, a major global pharmaceutical company, produces amoxicillin under the brand name Mox, available in various forms and dosages, and is a significant player in the generic amoxicillin market, with a presence in numerous countries. In 2020, Sun Pharma reportedly provided access to its amoxicillin/clavulanic acid to 890,000 patients across 19 access countries, demonstrating its commitment to global healthcare, and while the company does not disclose specific production percentages, it maintains strategies for continuous supply and mitigating stockouts by holding buffer stocks and using multiple suppliers. Sun Pharma also has a state-of-the-art manufacturing facility that produces amoxicillin and is committed to adhering to GMP standards, ensuring consistent quality. You can find more information about Sun Pharma's products here.

Astellas Pharma

Astellas Pharma, a Japanese multinational pharmaceutical company formed in 2005, produces amoxicillin-based medications, including Sawacillin, which has been approved for pediatric infectious diseases and H. pylori eradication in Japan, with precursors for their amoxicillin products sourced from China. While they don't manufacture the active substance in the Netherlands, Astellas is a key supplier of amoxicillin, significantly impacting the market, although specific global production percentages are not available and they have temporarily paused some antibiotic production in Russia. For more detailed information, you can visit their official website.

Dr. Reddy's Laboratories

Dr. Reddy's Laboratories, a global pharmaceutical leader, is recognized for its high-quality amoxicillin production, with a commitment to manufacturing excellence and contributing significantly to the global supply of this essential antibiotic; in 2023, they produced over 100 million units of amoxicillin-based formulations, showcasing their strong manufacturing capabilities; Dr. Reddy's consistently ensures rigorous quality control, adhering to the highest international standards in its production processes; their dedication to accessible and affordable healthcare solutions is reflected in their amoxicillin offerings, making them a trusted choice for healthcare professionals and patients alike; globally, Dr. Reddy's has a market share of approximately 10% in amoxicillin production, cementing their status as a key player in this essential pharmaceutical market.